We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

82 hedge funds and large institutions have $75.4M invested in VanEck Biotech ETF in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

654% more call options, than puts

Call options by funds: $1.82M | Put options by funds: $241K

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0% more funds holding

Funds holding: 82 → 82 (0)

9.71% less ownership

Funds ownership: 26.63% → 16.92% (-9.7%)

43% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 28

58% less capital invested

Capital invested by funds: $179M → $75.4M (-$104M)

Holders
82
Holders Change
–
Holders Change %
0%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
16
Reduced
28
Closed
14
Calls
$1.82M
Puts
$241K
Net Calls
+$1.58M
Net Calls Change
+$1M

Top Buyers

Rank Fund Capital Flow
1
AL
Aspiriant LLC
California
+$1.43M
2
PA
Pinnacle Associates
New York
+$949K
3
PAG
Private Advisor Group
New Jersey
+$773K
4
PSF
Pacific Sun Financial
California
+$702K
5
Goldman Sachs
Goldman Sachs
New York
+$444K

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$77.8M
2
ECM
Endurant Capital Management
California
-$6.22M
3
CG
Colony Group
Massachusetts
-$4.9M
4
TC
Trust Company
Kansas
-$4.33M
5
WI
WBI Investments
New Jersey
-$2.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
JCM
76
Jacobi Capital Management
Pennsylvania
$7K – – –
BWM
77
Baystate Wealth Management
Massachusetts
$6K +$6.27K +50 New
SWP
78
Stratos Wealth Partners
Ohio
$5K -$268K -2,132 -98%
QAM
79
QCI Asset Management
New York
$3K – – –
AIP
80
Ameritas Investment Partners
Nebraska
$2K -$3.77K -30 -60%
SWM
81
SeaCrest Wealth Management
New York
$2K – – –
AllianceBernstein
82
AllianceBernstein
Tennessee
– -$77.8M -624,508 Closed
ECM
83
Endurant Capital Management
California
– -$6.22M -49,899 Closed
CG
84
Colony Group
Massachusetts
– -$4.9M -39,318 Closed
TC
85
Trust Company
Kansas
– -$4.33M -34,782 Closed
WI
86
WBI Investments
New Jersey
– -$2.61M -20,934 Closed
OLA
87
Oliver Luxxe Assets
New Jersey
– -$1.57M -12,623 Closed
VWA
88
V Wealth Advisors
Kansas
– -$427K -3,312 Closed
TSS
89
Two Sigma Securities
New York
– -$243K -1,947 Closed
CAM
90
Covenant Asset Management
New Jersey
– -$236K -1,892 Closed
BRWA
91
B. Riley Wealth Advisors
Florida
– -$229K -1,831 Closed
BRF
92
B. Riley Financial
California
– -$202K -1,619 Closed
TC
93
Telemus Capital
Michigan
– -$128K -1,030 Closed
CPIG
94
Chicago Partners Investment Group
Illinois
– -$75K -600 Closed
FAAS
95
First Allied Advisory Services
California
– -$53K -434 Closed
1 2 3
4

BBH Hedge Fund Activity: Q1 2018 in Review

82 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2018, worth a combined $75.4M — down 58% from $179M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new BBH positions and 14 closed out — a net gain of 1 holder — while 16 added to existing stakes and 28 trimmed.

The largest buyer was Aspiriant LLC, opening a new position worth an estimated $1.43M. The largest seller was AllianceBernstein, exiting entirely with an estimated $77.8M sold.

  • 82 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $75.4M of VanEck Biotech ETF stock for Q1 2018, down 58% quarter-over-quarter.
  • 15 funds opened new VanEck Biotech ETF positions in Q1 2018 and 14 closed out, a net change of +1 holder.
  • The largest VanEck Biotech ETF buyer in Q1 2018 was Aspiriant LLC, an estimated $1.43M added.
  • The largest VanEck Biotech ETF seller in Q1 2018 was AllianceBernstein, an estimated $77.8M sold.

Based on aggregated 13F filings for Q1 2018.